BBOT
BridgeBio Oncology Therapeutics, Inc.
NASDAQ: BBOT · HEALTHCARE · BIOTECHNOLOGY
$8.41
+4.34% today
Updated 2026-04-30
Market cap
$702.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.30
Dividend yield
—
52W range
$8 – $15
Volume
0.3M
BridgeBio Oncology Therapeutics, Inc. (BBOT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-48.20%
ROA
-29.70%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | — | $-43357.00 | — | — | — |
| 2022 | — | $-3520.00 | — | — | — |
| 2023 | $0.00 | $-64.70M | — | — | — |
| 2024 | $0.00 | $-74.28M | — | — | — |
| 2025 | $0.00 | $-134.04M | — | — | — |